MORGAN E RABACH
Allopathic & Osteopathic Physicians|Dermatology NEW YORK, NY NPI 1013191204
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology NY GENZYME CORPORATION All categories
General Payments — all program years on this page
$12,472.71
- Category: General Payments
- Program years: PY2018–2024
- Record count: 131
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $173.68 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.68 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $67.91 | 3 |
| REVANCE THERAPEUTICS, INC. | $54.55 | 1 |
| ABBVIE INC. | $33.33 | 2 |
| Amgen Inc. | $17.89 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105341312 | ABBVIE INC. | $15.32 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105341316 | ABBVIE INC. | $18.01 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117660781 | Amgen Inc. | $17.89 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139652447 | GENZYME CORPORATION | $22.58 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139652477 | GENZYME CORPORATION | $18.60 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139652511 | GENZYME CORPORATION | $26.73 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147927115 | REVANCE THERAPEUTICS, INC. | $54.55 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.